{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:13:18Z","timestamp":1792087998625,"version":"4.4.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2720,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/modpathol.2015.77","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T07:41:58Z","timestamp":1434699718000},"page":"1101-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)"],"prefix":"10.1016","volume":"28","author":[{"given":"W Glenn","family":"McCluggage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan J","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise A","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin JR","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Hirschowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.77_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/his.12042","article-title":"Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting","volume":"62","author":"Kench","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PGP.0b013e31825d808b","article-title":"Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia","volume":"32","author":"McCluggage","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/PAS.0b013e31829d7f35","article-title":"Data set for pathology reporting of cutaneous invasive melanoma recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"37","author":"Scolyer","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.5858\/arpa.2012-0511-OA","article-title":"Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting","volume":"137","author":"Jones","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.77_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1038\/modpathol.2015.77_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1038\/modpathol.2015.77_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3802\/jgo.2013.24.1.66","article-title":"Major clinical research advances in gynecologic cancer in 2012","volume":"24","author":"Suh","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2012.12.003","article-title":"Impact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysis","volume":"39","author":"Kim","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/modpathol.2015.77_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2015.77_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/AOG.0b013e3181917a0c","article-title":"Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer","volume":"113","author":"Bakkum-Gamez","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2015.77_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PGP.0b013e3181af2372","article-title":"Prognostic factors for stage I ovarian carcinoma","volume":"29","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib12","first-page":"263","article-title":"Prognostic factors in patients with stage I epithelial ovarian cancer","volume":"75","author":"Dembo","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2015.77_bib13","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1200\/JCO.1996.14.11.2968","article-title":"Natural history and prognosis of untreated stage I epithelial ovarian carcinoma","volume":"14","author":"Ahmed","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.77_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/IGC.0b013e3181991546","article-title":"Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial","volume":"19","author":"Timmers","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2011.08.036","article-title":"Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types","volume":"123","author":"Higashi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1701-2163(15)30790-8","article-title":"Endometrioid ovarian carcinoma during pregnancy presenting with acute rupture","volume":"35","author":"Gottheil","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1038\/modpathol.2015.77_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.77_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib21","first-page":"283A","article-title":"CCNE1 amplification may precede centrosome number abnormality in progression from serous tubal intraepithelial carcinoma to high-grade serous carcinoma","volume":"26","author":"Kuhn","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib22","first-page":"276A","article-title":"Practical value of systematic and complete examination of fallopian tubes in unselected women undergoing salpingectomy for benign indications: results of a prospective study","volume":"26","author":"Garg","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.12419","article-title":"Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal","volume":"65","author":"Singh","year":"2014","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ijgc-00009577-200601000-00006","article-title":"Sampling the omentum in ovarian neoplasia: when one block is enough","volume":"16","author":"Doig","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib28","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.5858\/2007-131-1578-OFGCHM","article-title":"Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination?","volume":"131","author":"Usub\u00fct\u00fcn","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.77_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2004.03.004","article-title":"Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images","volume":"35","author":"Seidman","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib30","series-title":"WHO Classification of Tumours of the Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","article-title":"My approach to and thoughts on typing of ovarian carcinomas","volume":"61","author":"McCluggage","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2015.77_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","article-title":"Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data","volume":"23","author":"Gilks","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib34","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jcp.55.5.321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?","volume":"55","author":"McCluggage","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.12386","article-title":"Review of findings in prophylactic gynaecologic specimens in Lynch syndrome with literature review and recommendations for grossing","volume":"65","author":"Downes","year":"2014","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas","volume":"29","author":"K\u00f6bel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib39","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23390","article-title":"Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"112","author":"Chan","year":"2008","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up","volume":"82","author":"Shimizu","year":"1998","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ygyno.2006.05.030","article-title":"Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum","volume":"103","author":"Seidman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib43","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/cncr.26618","article-title":"Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study","volume":"118","author":"Bodurka","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PGP.0b013e3181f71264","article-title":"Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group","volume":"30","author":"Yamamoto","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-0142(19950101)75:1<81::AID-CNCR2820750114>3.0.CO;2-F","article-title":"The utility of the revised International Federation of Gynecology and Obstetrics histologic grading system. A Gynecologic Oncology Group Study","volume":"75","author":"Zaino","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib46","first-page":"119","article-title":"An analysis of two versus three grades for endometrial carcinoma","volume":"92","author":"Taylor","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0029-7844(98)00116-1","article-title":"Prognostic validity of neoplastic cells with notable nuclear atypia in endometrial cancer","volume":"92","author":"Takeshima","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2015.77_bib48","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib49","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/cncr.20040","article-title":"Prognostic significance and interobserver variability of histologic grading system for endometrial carcinoma","volume":"100","author":"Scholten","year":"2004","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.pas.0000152129.81363.d2","article-title":"Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems","volume":"29","author":"Alkushi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib51","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.humpath.2004.03.005","article-title":"Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives","volume":"35","author":"Bell","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib52","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014serous tumours","author":"Seidman","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib53","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014endometrioid and endometrioid stromal tumours","author":"Ellenson","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib54","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014clear cell tumours","author":"Gilks","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib55","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014Brenner tumours","author":"Gilks","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib56","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014seromucinous tumours","author":"K\u00f6bel","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib57","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","article-title":"Tumours of the ovary: epithelial tumours\u2014mucinous tumours","author":"Longacre","year":"2014"},{"key":"10.1038\/modpathol.2015.77_bib58","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.humpath.2004.03.006","article-title":"Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior","volume":"35","author":"Ronnett","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib59","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.pas.0000213299.11649.fa","article-title":"Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib60","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4293","article-title":"Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants","volume":"232","author":"Ardighieri","year":"2014","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.77_bib64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib65","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma (STIC) based on morphologic and immunohistochemical features. A reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib68","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathology"},{"key":"10.1038\/modpathol.2015.77_bib69","first-page":"302A","article-title":"Intramucosal growth in fallopian tube fimbriae by tumors of non-gynecologic origin may mimic serous tubal intraepithelial carcinoma and tubal mucinous metaplasia","volume":"27","author":"Rabban","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004347-200404000-00002","article-title":"WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib71","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/IGC.0b013e3181bf8111","article-title":"Lymph node-positive stage IIIC ovarian cancer. A separate entity?","volume":"19","author":"Berek","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib72","first-page":"302","article-title":"Stage IIIC ovarian\/ peritoneal serous carcinoma: a heterogenous group of patients with different prognosis","volume":"33","author":"Bakker","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/IGC.0b013e3181991a49","article-title":"Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors)","volume":"19","author":"Fadare","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib74","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2015.77_bib75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.pas.0000194743.33540.e6","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e31825793e1","article-title":"Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma","volume":"36","author":"Djordjevic","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib77","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2015.77_bib78","first-page":"9","article-title":"Cancer statistics,2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2015.77_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/his.12028","article-title":"Hereditary gynaecological malignancies: advances in screening and treatment","volume":"62","author":"Folkins","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib80","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"26","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.77_bib81","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib82","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PAS.0b013e31825d9b8d","article-title":"Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria. Identification of a BRCA1 ovarian cancer phenotype","volume":"36","author":"Fujiwara","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/cancers2010088","article-title":"Targeted therapies in epithelial ovarian cancer","volume":"2","author":"Dean","year":"2010","journal-title":"Cancers"},{"key":"10.1038\/modpathol.2015.77_bib84","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAP.0b013e3182a92cf8","article-title":"Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor type","volume":"20","author":"Chui","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2015.77_bib85","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03367.x","article-title":"Synchronous tumours of the female genital tract","volume":"56","author":"Singh","year":"2010","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib86","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib87","series-title":"Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions","first-page":"1","article-title":"Overview of soft tissue tumors","author":"Miettinen","year":"2010"},{"key":"10.1038\/modpathol.2015.77_bib88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0090-8258(90)90050-U","article-title":"Histologic sampling requirements in ovarian carcinoma: a review of 51 tumors","volume":"38","author":"Gramlich","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib89","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","article-title":"Borderline ovarian tumors: key points and workshop summary","volume":"35","author":"Silverberg","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib90","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib91","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2005.10.008","article-title":"Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality","volume":"101","author":"Khunamornpong","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000478-200202000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas","volume":"26","author":"Rodr\u00edguez","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib93","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'","volume":"24","author":"Lee","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib94","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/1097-0142(20001001)89:7<1541::AID-CNCR18>3.0.CO;2-9","article-title":"Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases","volume":"89","author":"Nomura","year":"2000","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib95","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/modpathol.3800366","volume":"18","author":"Chen","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pgp.0000159935.38913.57","article-title":"Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature","volume":"24","author":"Ludwick","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PGP.0b013e3181bbbcc1","article-title":"Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases","volume":"29","author":"Tabrizi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib98","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2559.2000.01015.x","article-title":"Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases","volume":"37","author":"Ariyoshi","year":"2000","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2005.07.119","article-title":"Carcinosarcoma of the ovary-a case series","volume":"100","author":"Rutledge","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/IGC.0000000000000083","article-title":"Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: a Taiwanese Gynecologic Oncology Group Study","volume":"24","author":"Lu","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib101","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.77_bib102","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"Rodel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.77_bib103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","article-title":"Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy","volume":"236","author":"Ruo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1038\/modpathol.2015.77_bib104","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"30","author":"Wolmark","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1038\/modpathol.2015.77_bib105","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10350-005-0133-6","article-title":"Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer","volume":"48","author":"Gavioli","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1038\/modpathol.2015.77_bib106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","article-title":"A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival","volume":"12","author":"Ogston","year":"2003","journal-title":"Breast"},{"key":"10.1038\/modpathol.2015.77_bib107","first-page":"297","article-title":"Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome","volume":"180","author":"Sataloff","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1038\/modpathol.2015.77_bib108","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2012-0290-OA","article-title":"Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application","volume":"137","author":"Corben","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2015.77_bib109","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlation","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"10.1038\/modpathol.2015.77_bib111","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.humpath.2012.01.020","article-title":"International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems","volume":"43","author":"Chetty","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib112","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jclinpath-2012-201054","article-title":"Pathological grading of regression: an International Study Group perspective","volume":"65","author":"Chetty","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-012-1193-3","article-title":"A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation","volume":"460","author":"Chetty","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2015.77_bib114","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fonc.2013.00262","article-title":"Tumor Regression grading of gastrointestinal carcinomas after neoadjuvant treatment","volume":"3","author":"Thies","year":"2013","journal-title":"Front Oncol"},{"key":"10.1038\/modpathol.2015.77_bib115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2007.03.029","article-title":"Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking","volume":"106","author":"Le","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib116","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2013.09.030","article-title":"Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery","volume":"131","author":"Muraji","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib117","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2014.06.034","article-title":"Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer","volume":"211","author":"Petrillo","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/modpathol.2015.77_bib118","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.humpath.2006.12.008","article-title":"Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer","volume":"38","author":"Sassen","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.77_bib119","first-page":"276A","article-title":"Development of a response scoring system to quantify the effect of neoadjuvant chemotherapy in ovarian cancer\u2014ovarian cancer response scoring (OCRS) study","volume":"27","author":"Boehm","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jcp.53.7.558","article-title":"Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms","volume":"53","author":"McCluggage","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2559.2002.01384.x","article-title":"Recent advances in immunohistochemistry in gynaecological pathology","volume":"46","author":"McCluggage","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2005.11.002","article-title":"Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors","volume":"22","author":"McCluggage","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/modpathol.2015.77_bib123","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WTI immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","article-title":"WT1 is expressed in serous, but not in endometrioid, clear cell or mucinous carcinoma of the peritoneum, fallopian tube, ovaries and endometrium","volume":"23","author":"Acs","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib127","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms' tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/00313020802320697","article-title":"WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis","volume":"40","author":"Stewart","year":"2008","journal-title":"Pathology"},{"key":"10.1038\/modpathol.2015.77_bib129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2559.2007.02682.x","article-title":"High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour","volume":"50","author":"O'Neill","year":"2007","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0b013e3181ff400e","article-title":"Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases","volume":"35","author":"DeLair","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2014.61","article-title":"Napsin A is a specific marker for ovarian clear cell adenocarcinoma","volume":"28","author":"Yamashita","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.77_bib132","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2559.2005.02194.x","article-title":"Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features","volume":"47","author":"McCluggage","year":"2005","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib133","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib134","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-200210000-00009","article-title":"Cytokeratins 7 and 20, Dpc4 and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous carcinomas: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib135","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib136","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib137","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib138","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib139","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/PAS.0b013e3181758831","article-title":"Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms","volume":"32","author":"Ronnett","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib140","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.pas.0000213365.56498.72","article-title":"Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors)","volume":"31","author":"McCluggage","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib141","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0b013e31817c1b0a","article-title":"SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor","volume":"27","author":"Zhao","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib142","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAS.0b013e318188373d","article-title":"Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors","volume":"33","author":"Zhao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib143","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib144","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.pgp.0000167113.86586.65","article-title":"A strategy for defining biologically relevant levels of p53 protein expression in clinical samples with reference to endometrial neoplasia","volume":"24","author":"McCluggage","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2015.77_bib145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"Kobel","year":"2010","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2015.77_bib146","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2559.2011.03907.x","article-title":"Patterns of p53 immunoreactivity in endometrial carcinomas: \u2018all or nothing\u2019 staining is of importance","volume":"59","author":"McCluggage","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib147","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinoma: a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group Study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib148","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-2243(92)90195-5","article-title":"Synchronous primary malignancies of the female genital tract","volume":"45","author":"Ayhan","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1038\/modpathol.2015.77_bib149","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2559.2009.03390.x","article-title":"WT1, p53 and hormone receptor expression in uterine serous carcinoma","volume":"55","author":"Hirschowitz","year":"2009","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jcp.2010.086074","article-title":"Peritoneal mesothelial hyperplasia associated with gynaecological disease: a potential diagnostic pitfall that is commonly associated with endometriosis","volume":"64","author":"Oparka","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.77_bib151","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2015.77_bib152","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.77_bib153","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2015.77_bib154","doi-asserted-by":"crossref","first-page":"740968","DOI":"10.1155\/2010\/740968","article-title":"Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma","volume":"2010","author":"Gilks","year":"2010","journal-title":"J Oncol"},{"key":"10.1038\/modpathol.2015.77_bib155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0b013e31827bc24d","article-title":"Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms","volume":"20","author":"Maeda","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2015.77_bib156","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","article-title":"K-ras mutations in mucinous ovarian tumors","volume":"79","author":"Cuatrecasas","year":"1997","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.77_bib157","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.77_bib158","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.31","article-title":"Significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"1","author":"Matsuo","year":"2012","journal-title":"Cancer Med"},{"key":"10.1038\/modpathol.2015.77_bib159","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0000000000000240","article-title":"Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer","volume":"123","author":"Matsuo","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2015.77_bib160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/IGC.0b013e3181e02fc7","article-title":"The grading of lymphovascular space invasion in epithelial ovarian carcinoma","volume":"20","author":"Qian","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2015.77_bib161","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anndiagpath.2012.10.001","article-title":"Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors","volume":"17","author":"Alvarado-Cabrero","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/modpathol.2015.77_bib162","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib163","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0090-8258(88)90022-4","article-title":"Primary adenocarcinoma localized to the fallopian tubes: report on 33 cases","volume":"30","author":"Asmussen","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2015.77_bib164","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:37Z","timestamp":1760230117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":164,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0893395222013928"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.77","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.77","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}